Treatment with cisplatin and vinorelbine in patients with squamous cell carcinoma of the head and neck.

被引：0
|
作者：
De la Llaba, J [1 ]
García, AL [1 ]
Aranda, F [1 ]
Barncío, IC [1 ]
Méndez, MI [1 ]
Aranda, E [1 ]
机构：
[1] Hosp Cordoba, Dept Med Oncol, Cordoba, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S64 / S64
页数：1
相关论文
共 50 条
  • [1] Hyperfractionated radiation therapy for the treatment of squamous cell carcinoma of the head and neck.
    Karasawa, K
    Umezawa, T
    Hanyu, N
    Kawamura, H
    Kiguchi, Y
    Mitsuhashi, T
    Niibe, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 501S - 501S
  • [2] A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Espinosa, E
    Zamora, P
    Millá, A
    Morales, S
    Molina, R
    Mira, M
    Barón, MG
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (12): : 1054 - 1059
  • [3] Gemcitabine versus cisplatin concomitant with radiotherapy for locally advanced squamous cell carcinoma of the head and neck.
    Ali, Elsayed Mostafa
    Hassan, Emad Nabil
    Elyamany, Ashraf
    Maklad, Ahmed M.
    Abdelraheem, Ahmed Gaber
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] CISPLATIN IN THE TREATMENT OF HEAD AND NECK SQUAMOUS CARCINOMA
    CUNNINGHAM, JD
    EAR NOSE & THROAT JOURNAL, 1983, 62 (04): : 199 - 206
  • [5] Systemic therapy in patients with advanced cutaneous squamous cell carcinoma of the head and neck.
    Tam, Samantha
    Gajera, Mona
    Luo, Xiaoning
    Glisson, Bonnie S.
    Ferrarotto, Renata
    Rosenthal, David Ira
    Weber, Randal S.
    Myers, Jeffrey
    Gross, Neil D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Expression of topoisomerase II in squamous cell carcinoma of the head and neck.
    Haines, GK
    Zielinski, M
    Brown, T
    Leyland, J
    Radosevich, JA
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (07) : A355 - A355
  • [7] VINORELBINE PLUS CISPLATIN IN RECURRENT OR PREVIOUSLY UNTREATED UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    GEBBIA, V
    TESTA, A
    DIGREGORIO, C
    INGRIA, F
    VALENZA, R
    CANNATA, G
    MOSCHELLA, F
    RESTIVO, G
    GEBBIA, N
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (04): : 293 - 296
  • [8] Cervical metastasis of squamous cell carcinoma of the head and neck. Therapeutic options
    Gallegos-Hernandez, Jose F.
    Abrego-Vazquez, Jose A.
    Olvera-Casas, Aldo
    Minauro-Munoz, Gerardo G.
    Ortiz-Maldonado, Alma L.
    CIRUGIA Y CIRUJANOS, 2019, 87 (02): : 141 - 145
  • [9] Concomitant chemoradiotherapy using docetaxel, cisplatin and 5-FU (TPF) for the patients with advanced squamous cell carcinoma of the head and neck.
    Shiga, Kiyoto
    Katagiri, Katsunori
    Saitoh, Daisuke
    Oikawat, Shin-ichi
    Ikeda, Aya
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Weekly Docetaxel, Cisplatin, and Cetuximab in Palliative Treatment of Patients with Squamous Cell Carcinoma of the Head and Neck
    Trieu, Vanessa
    Pinto, Harlan
    Riess, Jonathan W.
    Lira, Ruth
    Luciano, Richard
    Coty, Jessie
    Boothroyd, Derek
    Colevas, A. Dimitrios
    ONCOLOGIST, 2018, 23 (07): : 764 - +
12345